Severe thromboembolic phenomenon in the setting of pseudoprogression of melanoma brain metastases in response to combination immunotherapy

Approximately half of patients with metastatic melanoma develop brain metastasis (MBM) in their disease course. However, patients with MBM were often excluded from early immunotherapy trials, and therefore, the role of immunotherapy in these patients is less clear. We review the case of a patient wi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMJ Case Rep
Prif Awduron: Perez, Matthew C, Yu, Hsiang-Hsuan M, Markowitz, Joseph
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2018
Pynciau:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6101337/
https://ncbi.nlm.nih.gov/pubmed/30108120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-226089
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg